TrialThe Journal of urology2019

Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.

Baowei Fei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.